+ 50 Products Commercialized
+ 60 Years of Experience
+ 94 Million Patients Treated
+ 148 Countries Served
+ 16 Manufacturing Facilities
+ 250+ Experts in Industrial R&D
Guaranteed To Reduce Your Time-To-Market
Servier offers a variety of tableting and encapsulation options to optimize your product’s therapeutic performance. Our tablet capabilities range from immediate, controlled and modified release to film and sugar coating, and we have the equipment and expertise to encapsulate powders, granules and micro-tablets.
We have high-performance production capabilities for a full range of dosage forms and product groups, including liquids, sprays and powders. Our manufacturing and packaging suites have separate air handling and filtration systems to ensure full quality control and assurance across the lifecycle of your product.
Servier provides custom manufacturing of APIs and HPAPIs from worldwide facilities. Our industry-leading methodologies, combined with state-of-the-art containment tools, enables us to handle your project from development through commercial phases, addressing any technical and regulatory challenges that may arise.
We manufacture pharmaceutical intermediates from state-of-the-art cGMP and FDA-approved chemical facilities around the world. Leveraging our integrated network of R&D, production and supply chain expertise, we provide intermediate manufacturing for both GMP and non-GMP requirements, from kilogram scale to several metric tons.
At Servier, we provide a number of cost-effective primary and secondary packaging options, including blisters, sachets and bottles. We strictly adhere to global standards for serialization and aggregation, and provide tamper-evident packaging and labeling in line with EU requirements.
Our pharmaceutical manufacturing plant in Madrid is certified in European registration dossiers for several current Servier Group products. The site’s state-of-the-art facilities and technology ensure high containment of your product during key stages of processing.
Servier’s Oril Industrie facility in Bolbec specializes in the development and manufacture of intermediates, APIs and HPAPIs for worldwide distribution.
Servier provides clinical supply, drug product, packaging and supply chain support from four state-of-the-art production facilities in Gidy, France.
Servier manufactures multiple solid dosage forms from our South Dublin high-potency facility, our largest production plant outside of France.
Servier’s Warsaw facility provides large-scale, EMA-grade drug product manufacturing and packaging with competitive pricing and lead times.
Servier Morocco manufactures drug product for the Moroccan market and 13 African countries, as well as generic products for Biogaran France, Servier’s generics subsidiary.
Servier Egypt manufactures and distributes more than 540 million units of drug product annually from two state-of-the-art facilities in Cairo.
Servier Brazil’s R&D, distribution and industrial production activities are located in Jacarepagua, approximately 75km west of Rio de Janeiro.
Servier Tianjin Pharmaceutical Co. Ltd provides drug product manufacturing for the local market, as well as GMP certified repacking production.
We provide clinical supply, drug product, packaging and supply chain support from four state-of-the-art production facilities in Gidy, France.
Our state-of-the-art facilities and technology in Madrid ensure high containment of your product during key stages of development.
Servier offers process development, analytical development and manufacturing services from our dedicated fine chemistry facility in Toledo.
We provide drug product manufacturing, packaging, supply chain and analytical services from our dedicated dry forms manufacturing facility in Moscow.
Aligning the Outsourcing Relationship
As outsourcing to pharmaceutical contract service providers increases, aligning the goals of sponsors and suppliers has become increasingly important. Servier, through its contract manufacturing division, is responding to this market demand by prioritizing strategic partnerships, our service offering, quality and compliance.
Paris, France, October 1, 2018 – Servier, an independent international pharmaceutical company, today announced the launch of InnoPreP™ – a new preparative chromatography service offered under its contract development and manufacturing business.
